Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma

NCT00792506 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Stopped The study was prematurely discontinued for lack of recruitement.

Conditions

Interventions

Sponsor

Italfarmaco